HAEMOPHILIA A
Clinical trials for HAEMOPHILIA A explained in plain language.
Never miss a new study
Get alerted when new HAEMOPHILIA A trials appear
Sign up with your email to follow new studies for HAEMOPHILIA A, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New Long-Term treatment aims to stop bleeds in haemophilia patients
Disease control OngoingThis study is testing the long-term safety and effectiveness of a new medicine called Mim8 for people with haemophilia A. Mim8 is designed to prevent bleeding episodes by helping the blood to clot. The study will follow participants for up to 5.5 years to see how well the treatme…
Matched conditions: HAEMOPHILIA A
Phase: PHASE3 • Sponsor: Novo Nordisk A/S • Aim: Disease control
Last updated Apr 02, 2026 04:27 UTC
-
Tracking hemophilia treatment over years in Real-World patients
Disease control ENROLLING_BY_INVITATIONThis study follows males with moderate to severe hemophilia A who are already using Esperoct® to prevent bleeding episodes. Researchers will track how well the treatment works and monitor any side effects over 5-7 years of regular use. Participants continue their normal treatment…
Matched conditions: HAEMOPHILIA A
Sponsor: Novo Nordisk A/S • Aim: Disease control
Last updated Mar 23, 2026 15:15 UTC
-
Researchers tap registry to monitor drug safety
Knowledge-focused ENROLLING_BY_INVITATIONThis study is collecting safety information from an existing European patient registry. It aims to monitor for any side effects in people with Hemophilia A who are being treated with the medication turoctocog alfa pegol. The study does not involve any new treatment or procedures …
Matched conditions: HAEMOPHILIA A
Sponsor: Novo Nordisk A/S • Aim: Knowledge-focused
Last updated Mar 18, 2026 18:25 UTC